Based on recent data, Inovio Pharmaceuticals, Inc. (INO) shows an Average True Range (ATR) of 0.12 and an Enterprise Value of 279.11M. Its average trading volume over the past 3 months is 1.44M, indicating liquidity. These fundamental metrics provide insight into INO's underlying financial health and market activity.
| ATR | 0.12 |
| Enterprise Value | 279.11M |
| Avg Vol (3 Months) | 1.44M |
| Avg Vol (10 Days) | 1.1M |
Inovio Pharmaceuticals, Inc. (INO) technical indicators as of February 26, 2026: the SMA 20 is 10.35%, SMA 50 at 4.73%, and SMA 200 at -6.44%. The RSI 14 value is 61.37, suggesting its current momentum. These technical analysis signals help assess INO's price trends and potential future movements.
| SMA 20 | 10.35% |
| SMA 50 | 4.73% |
| SMA 200 | -6.44% |
| RSI 14 | 61.37 |
Inovio Pharmaceuticals, Inc. (INO) stock performance overview as of February 26, 2026: The 52-week high is $2.98 (currently -37.9% below), and the 52-week low is $1.3 (currently 42.31% above). Over the past year, INO's performance is -20.94%, compared to the S&P 500's 10.91% change.
| 52-Week High | 2.98 |
| 52-Week High Chg | -37.90% |
| 52-Week Low | 1.3 |
| 52-Week Low Chg | +42.31% |
| S&P 500 52-Week Chg | 10.91% |
According to market data, Inovio Pharmaceuticals, Inc. (INO) stock's recent performance metrics show that over the last month, INO is -41.92%, with a Year-to-Date (YTD) performance of -13.22%. Over the past year, the stock has seen a -20.94% change. These figures summarize INO's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 2.03 | 2.03 | 2.72 | 2.98 | 2.98 | 2.03 |
| Low | 1.63 | 1.49 | 1.47 | 1.47 | 1.3 | 1.47 |
| Performance | -1.95% | -41.92% | -35.74% | +6.34% | -20.94% | -13.22% |
According to current financial data, INO stock's P/E (TTM) ratio is -0.91, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for INO, including P/S (554.01), P/B (-12.74), and P/FCF (-1.13), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | INO | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -0.91 | -1.23 | -5.16 | 32.59 |
| P/S (TTM) | 554.01 | 3.71 | 464.92 | 5.98 |
| P/B (TTM) | -12.74 | 142.25 | 9 | 5.26 |
| P/FCF (TTM) | -1.13 | -6.31 | -253.28 | 30.85 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep